| 1 |
32616215 | The role of eEF2 kinase in the rapid antidepressant actions of ketamine. | 2020 |
3 |
| 2 |
31488789 | Magnesium and ketamine in the treatment of depression. | 2019 Sep |
2 |
| 3 |
31827434 | Ketamine and Active Ketamine Metabolites Regulate STAT3 and the Type I Interferon Pathway in Human Microglia: Molecular Mechanisms Linked to the Antidepressant Effects of Ketamine. | 2019 |
2 |
| 4 |
27073354 | Practical application of the neuroregenerative properties of ketamine: real world treatment experience. | 2016 Feb |
2 |
| 5 |
24392693 | Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds. | 2014 |
2 |
| 6 |
23062356 | The role of eukaryotic elongation factor 2 kinase in rapid antidepressant action of ketamine. | 2013 Jun 15 |
2 |
| 7 |
23337256 | Sex differences in the antidepressant-like effects of ketamine. | 2013 Jul |
1 |
| 8 |
23534055 | Synaptic mechanisms underlying rapid antidepressant action of ketamine. | 2012 Nov |
3 |
| 9 |
21677641 | NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. | 2011 Jun 15 |
3 |